Anuh Pharma Intrinsic Value
Anuh Pharma (ANUHPHR) median intrinsic value is ₹156.88 from 9 valuation models (range ₹24–₹196), vs current price ₹78.44 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit ANUHPHR share price.
ANUHPHR Valuation Methods Summary — DCF, Graham Number & P/E
Anuh Pharma intrinsic value across 9 models vs current price ₹78.44 — upside/downside and value range per method. Browse ANUHPHR complete financial for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹136.40 | ₹109.12 - ₹163.68 | +73.9% | EPS: ₹6.20, Sector P/E: 22x |
| Book Value Method | asset | ₹196.10 | ₹176.49 - ₹215.71 | +150.0% | Book Value/Share: ₹130.40, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹156.88 | ₹141.19 - ₹172.57 | +100.0% | Revenue/Share: ₹311.20, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹156.88 | ₹141.19 - ₹172.57 | +100.0% | EBITDA: ₹68.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹157.08 | ₹125.66 - ₹188.50 | +100.3% | CF Growth: 8.5%, Discount: 15% |
| PEG Ratio Method | growth | ₹23.53 | ₹21.18 - ₹25.88 | -70.0% | EPS Growth: 0.4%, Fair P/E: 0.3x |
| Growth Adjusted P/E | growth | ₹98.64 | ₹88.78 - ₹108.50 | +25.8% | Revenue Growth: 12.1%, Adj P/E: 15.9x |
| ROE Based Valuation | profitability | ₹156.88 | ₹141.19 - ₹172.57 | +100.0% | ROE: 12.9%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹134.87 | ₹121.38 - ₹148.36 | +71.9% | EPS: ₹6.20, BVPS: ₹130.40 |
ANUHPHR Intrinsic Value vs Market Price — All Valuation Models
Anuh Pharma fair value range ₹24–₹196 vs current market price ₹78.44 across 9 valuation models. Compare with ANUHPHR fair price to assess whether the stock is under or overvalued.
ANUHPHR Intrinsic Value Analysis — Undervalued or Overvalued?
Anuh Pharma median intrinsic value ₹156.88, current price ₹78.44 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of ANUHPHR?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Anuh Pharma (ANUHPHR) is ₹156.88 (median value). With the current market price of ₹78.44, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹23.53 to ₹196.10, indicating ₹23.53 - ₹196.10.
Is ANUHPHR undervalued or overvalued?
Based on our multi-method analysis, Anuh Pharma (ANUHPHR) appears to be trading below calculated value by approximately 100.0%.
ANUHPHR Financial Health — Key Ratios vs Industry Benchmarks
Anuh Pharma financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 188.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 12.9% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.53x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
ANUHPHR Cash Flow Quality — Operating & Free Cash Flow
Anuh Pharma operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹37 Cr | ₹27 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹13 Cr | ₹13 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹54 Cr | ₹32 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹29 Cr | ₹25 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-19 Cr | ₹-19 Cr | Negative Cash Flow | 3/10 |